The<unk>  is a clinical prediction score assessing ischemic and bleeding risks at 12 to 30 months following  percutaneous coronary intervention (PCI) to inform the duration of dual antiplatelet therapy <unk> . The score was derived from the<unk>  study (ClinicalTrials.gov: NCT00977938) and initially validated in the PROTECT trial (ClinicalTrials.gov: NCT00476957).
DAPT score
MELD Score
HAS-BLED score
Partial thromboplastin time
AMUSE score
IMPROVE bleeding risk score
CHADS2 score
Prothrombin time